CN116918925A - 一种黑果花楸疏通微循环的饮料 - Google Patents
一种黑果花楸疏通微循环的饮料 Download PDFInfo
- Publication number
- CN116918925A CN116918925A CN202310824880.3A CN202310824880A CN116918925A CN 116918925 A CN116918925 A CN 116918925A CN 202310824880 A CN202310824880 A CN 202310824880A CN 116918925 A CN116918925 A CN 116918925A
- Authority
- CN
- China
- Prior art keywords
- beverage
- effects
- spleen
- dredging
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 30
- 240000005662 Aronia melanocarpa Species 0.000 title claims abstract description 24
- 235000007425 Aronia melanocarpa Nutrition 0.000 title claims abstract description 24
- 230000004089 microcirculation Effects 0.000 title claims abstract description 17
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 18
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 18
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 18
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 18
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 18
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 18
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 18
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 18
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 18
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 7
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 7
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 2
- 241000132012 Atractylodes Species 0.000 claims description 17
- 240000003915 Lophatherum gracile Species 0.000 claims description 14
- 241001092391 Sorbus Species 0.000 claims description 10
- 235000014459 Sorbus Nutrition 0.000 claims description 9
- 244000273928 Zingiber officinale Species 0.000 claims description 6
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 6
- 235000008397 ginger Nutrition 0.000 claims description 6
- 241000213006 Angelica dahurica Species 0.000 claims description 3
- 241001444063 Aronia Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 52
- 239000008280 blood Substances 0.000 abstract description 37
- 210000004369 blood Anatomy 0.000 abstract description 36
- 210000000952 spleen Anatomy 0.000 abstract description 25
- 235000000346 sugar Nutrition 0.000 abstract description 18
- 239000003814 drug Substances 0.000 abstract description 12
- 230000032683 aging Effects 0.000 abstract description 8
- 230000001965 increasing effect Effects 0.000 abstract description 7
- 210000003734 kidney Anatomy 0.000 abstract description 7
- 230000003213 activating effect Effects 0.000 abstract description 5
- 230000036528 appetite Effects 0.000 abstract description 4
- 235000019789 appetite Nutrition 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 4
- 210000005036 nerve Anatomy 0.000 abstract description 4
- 241000222336 Ganoderma Species 0.000 abstract description 3
- 230000003394 haemopoietic effect Effects 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 230000004936 stimulating effect Effects 0.000 abstract description 3
- 230000002936 tranquilizing effect Effects 0.000 abstract description 3
- 241001092040 Crataegus Species 0.000 description 16
- 206010030113 Oedema Diseases 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 10
- 235000019197 fats Nutrition 0.000 description 9
- 230000036772 blood pressure Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 230000003405 preventing effect Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 5
- 208000017574 dry cough Diseases 0.000 description 5
- 229930003935 flavonoid Natural products 0.000 description 5
- 150000002215 flavonoids Chemical class 0.000 description 5
- 235000017173 flavonoids Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010000234 Abortion spontaneous Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 208000015994 miscarriage Diseases 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 208000000995 spontaneous abortion Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 229930182837 (R)-adrenaline Natural products 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010024642 Listless Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000037831 Polygonatum sibiricum Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- -1 anthraquinone compounds Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000037304 dermatophytes Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229960005139 epinephrine Drugs 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 208000017971 listlessness Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000021049 nutrient content Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000005100 Herpetic Keratitis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 108010057186 Insulin Glargine Proteins 0.000 description 1
- COCFEDIXXNGUNL-RFKWWTKHSA-N Insulin glargine Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(=O)NCC(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 COCFEDIXXNGUNL-RFKWWTKHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241000745390 Lophatherum Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 206010073938 Ophthalmic herpes simplex Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 201000010618 Tinea cruris Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000002034 butanolic fraction Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- OEERIBPGRSLGEK-UHFFFAOYSA-N carbon dioxide;methanol Chemical compound OC.O=C=O OEERIBPGRSLGEK-UHFFFAOYSA-N 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960002869 insulin glargine Drugs 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000008345 mountainash Nutrition 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 238000007034 nitrosation reaction Methods 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 210000001599 sigmoid colon Anatomy 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及饮料技术领域,公开了一种黑果花楸疏通微循环的饮料,包括以下原材料:白芷、山楂、黄精、干姜、淡竹叶、龙眼肉、白术和黑果花楸调配而成。本发明的饮料具备补心血,益心气,安心神的效果,其中山楂醒脾开胃,更增加了脾的造血功效,黄精素来有灵芝草之称,补脾益气补肾益精是延年益寿的佳品,诸药合用,共奏健脾益气,养血补心,益智安神之效,更可增加心脏冠脉流量,调血脂、降血糖、抗衰老的功效,更值得说明的是,本发明的单独补充黑果花楸,还能够达到经络活血化瘀的作用。
Description
技术领域
本发明属于饮料技术领域,具体地说,涉及一种黑果花楸疏通微循环的饮料。
背景技术
饮料是供人饮用的液体,它是经过定量包装的,供直接饮用或按一定比例用水冲调或冲泡饮用的,乙醇含量(质量分量)不超过0.5%的制品,饮料也可分为饮料浓浆或固体形态,它的作用是解渴、补充能量等功能。
现有技术的饮料不具有疏通经络活血化瘀的作用,常见的功能性饮料多采用化学添加剂的方法,使其具有一定的口感和一定程度上的功能性,没有对人体进行良好的药理功能。
有鉴于此特提出本发明。
发明内容
为解决上述技术问题,本发明采用技术方案的基本构思是:
一种黑果花楸疏通微循环的饮料,包括以下原材料:白芷、山楂、黄精、淡竹叶、龙眼肉、白术和黑果花楸调配而成。
作为本发明的一种优选实施方式,按上述比例调配时,原材料的具体质量为:白芷为0.3—0.7Kg,山楂为2.5—3.5kg,黄精为5—7kg、淡竹叶为30—35kg。
作为本发明的一种优选实施方式,原材料的具体质量还包括:龙眼肉为3.5—5kg,白术为1.5—2.5kg。
作为本发明的一种优选实施方式,所述原材料还包括干姜。
作为本发明的一种优选实施方式,所述干姜的具体质量为2—2.8kg。
作为本发明的一种优选实施方式,所述黑果花楸的具体质量为2—3kg。
本发明与现有技术相比具有以下有益效果:
本发明的饮料具备补心血,益心气,安心神的效果,其中山楂醒脾开胃,更增加了脾的造血功效,黄精素来有灵芝草之称,补脾益气补肾益精是延年益寿的佳品,诸药合用,共奏健脾益气,养血补心,益智安神之效,更可增加心脏冠脉流量,调血脂、降血糖、抗衰老的功效,更值得说明的是,本发明的单独补充黑果花楸,还能够达到经络活血化瘀的作用。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例中的,对实施例中的技术方案进行清楚、完整地描述,以下实施例用于说明本发明。
一种黑果花楸疏通微循环的饮料,包括以下原材料:白芷、山楂、黄精、淡竹叶、龙眼肉、白术和黑果花楸调配而成。
按上述比例调配时,原材料的具体质量为:白芷为0.3—0.7Kg,山楂为2.5—3.5kg,黄精为5—7kg、淡竹叶为30—35kg。黑果花楸的具体质量为2—3kg。
原材料的具体质量还包括:龙眼肉为3.5—5kg,白术为1.5—2.5kg。
所述原材料还包括干姜。所述干姜的具体质量为2—2.8kg。
本发明的黑果花楸疏通微循环的饮料原材料中包含白术,白术具有如下的具体作用:
一、祛湿健脾
白术可以祛湿健脾,脾胃不好的人容易出现腹泻,水肿,带下等问题,此时如果在医生指导下服用白术,可以有效地去湿健脾,改善腹泻,身体水肿,食欲不振等症状。
二、固表止汗
白术有很好的固表止汗的作用,脾虚的人可能会不停的出虚汗的人,这会让身体更加虚弱,此时可以适当的服用一些白术,就可以有效的缓解自汗症状。
三、利尿消肿
因为白术可以去湿,所以对于多种原因引起的身体浮肿有很好的疗效,比如肾病引起的水肿,肝病引起的水肿,营养不良引起的水肿,怀孕导致的身体浮肿等,都可以服用白术去湿利尿,消除水肿。
四、增强免疫力
因为白术可以增强白细胞吞噬病菌的能力,所以服用白术可以增强身体免疫力,有益健康。
五、安胎
白术有安胎的功效,如果孕妇身体比较弱,有先兆流产的症状,可以在医生指导下服用白术进行安胎。
六、抗氧化
白术有很好的抗氧化作用,所以可以有效的清除身体中的自由基,不但让身体更健康,还能起到延缓衰老的作用。
七、美容养颜
白术有抗氧化的作用,可以延缓皮肤衰老,有效的淡斑祛斑,经常应用白术能让皮肤变得越来越光滑白嫩,所以白术有美容养颜的作用,可以用白醋和白术制作面膜敷脸,能有效的祛斑美白。
茯苓的功效通常有利水消肿、健脾宁心等,可以缓解水肿、腹泻、食欲不振等症状。
另外,现代营养学认为,白茯苓还含有丰富的化学成分,如茯苓酸、蛋白质、脂肪、卵磷脂、组氨酸、麦角甾醇等,使用茯苓不仅能够及时补充人体所需要的营养,还有降血糖以及促进造血功能等药理作用。如果符合白茯苓的适应证,就可以到中医科就诊,明确辨证后遵医嘱使用该药,达到良好的治疗效果。对于那些有高血压或者是有水肿的病人也是可以辅助治疗的、并且还有清心的作用。
本发明的黑果花楸疏通微循环的饮料原材料中包含淡竹叶,淡竹叶具有如下的具体作用:
1、淡竹叶中的黄酮类物质有明显的扩张动脉、增强血管弹性、清理血液垃圾的作用;能明显改善心肌缺血、缩小心梗范围、对心脏缺血和脑缺血有一定的保护作用。
2、临床应用证明、淡竹叶能显着增加尿中氯化钠的含量,所以对于高钠引起的高血压和水肿等病症有辅助治疗3、淡竹叶中天然蕴含的竹醌具有杀菌、抑菌、消炎等作用、经功能性试验、淡竹叶对金黄色葡萄球菌、溶血性链球菌有明显的抑制作用。
4、淡竹叶可“去烦热、利小便、清心。”
经动物试验证明、淡竹叶有解热、利尿作用。
5、淡竹叶中的黄酮类物质能增强人体免疫功能、从而提高人体对不良环境和疾病的抵抗能力。
6、淡竹叶中的黄酮类物质能有效抵抗自由基、具有类sod活性、对亚硝化反应的具有良好的阻断能力、有较强的抗氧化功能、而人体的衰老过程实际上就是氧化的过程。
7、淡竹叶中含有丰富的叶绿素、叶绿素是许多绿叶植物抗诱变作用的重要成分、具有抗肿瘤、防癌变的功效。
8、淡竹叶中的黄酮类物质能有效降低甘油三酯和胆固醇的浓度、升高高密度脂蛋白、降低低密度脂蛋白。山楂的功效与作用。
本发明的黑果花楸疏通微循环的饮料原材料中包含山楂,山楂具有如下的具体作用:
1、强心、降血脂、降血压
有研究表明,山楂能防治心血管疾病,降低血清胆固醇及甘油三酯,有效防治动脉粥样硬化;山楂还能通过增强心肌收缩力、增加心输出量等,起到强心和预防心绞痛的作用。
此外,山楂中的总黄酮有扩张血管和持久降压的作用。因此,高血脂、高血压及冠心病患者,每日可取生山楂15~30克,水煎代茶饮。
2、治疗痛经、月经不调
山楂具有活血化淤的作用,是血淤型痛经患者的食疗佳品。血淤型痛经患者常表现为行经第1~2天或经前1~2天发生小腹疼痛,待经血排出流畅时,疼痛逐渐减轻或消失,且经血颜色暗,伴有血块。
3、开胃
山楂食用可开胃消食,特别对消肉食积滞作用更好,很多助消化的药中都采用了山楂。
4、可治疗腹泻
山楂中有平喘化痰、抑制细菌、治疗腹痛腹泻的成分。
5、抗衰老
山楂所含的黄酮类和维生素C、胡萝卜素等物质能阻断并减少自由基的生成,能增强机体的免疫力,有防衰老、抗癌的作用。黄精是临床上常用的一种补阴药物,其药性甘、平,归于肺、肾、脾经,具有养阴润肺,补脾益气的功效。此药在临床上可以用来治疗阴虚肺燥导致的咳嗽痰少或干咳无痰等疾病。还可以用来治疗阴血不足证导致的疾病。
此外,对于脾胃虚弱导致的饮食减少,神疲体倦,舌干少津等均有一定的治疗效果。
本发明的黑果花楸疏通微循环的饮料原材料中包含黄精,黄精具有如下的具体作用:
此药在临床上可以用来治疗以下疾病:
1、此药可以用来治疗阴虚肺燥导致的咳嗽痰少,干咳无痰等疾病,可以单用此药熬膏使用。
2、此药可以用来治疗阴血不足证导致的多种疾病。
3、此药可以用来治疗脾胃虚弱,饮食减少,神疲体倦,舌干少津,病后虚弱,体倦乏力等疾病,对于气虚精亏,以此达到补气滋肾生精的功效。
现代意义:
现代药理研究,此药具有抗炎,镇痛,镇定,降血压,降血糖,抗菌的作用。
对于金黄色葡萄球菌、结核杆菌、伤寒杆菌,以及多种皮肤真菌等均有一定的抑制作用。
现代应用此药,可以用来治疗高血压,糖尿病,股癣,牛皮癣等多种疾病。抑菌防病、降血糖、滋阴润肺、增强免疫力功效/
主治:
1、抑菌防病黄精能够起到一定的抑菌与抗菌的效果,而且还能够缓解由于皮肤真菌所引发的一些病症。除此之外,还能够加强心肌功能,预防一些心血管方面的病症发生。
2、降血糖现代医学研究证实,黄精含有黏质液、淀粉、糖类、天门冬氨酸、高丝氨酸、醌类、强心苷等,能降低血压,使冠状动脉的血流量有所增加,能抑制尿糖和血糖,特别是对肾上腺素引起的血糖过高有明显的抑制作用。
3、滋阴润肺黄精具有很好的滋阴润肺的效果,同时还能达到生津止渴、补肾强身的效果,对于益脾养血也会起到很好的作用。
因此,黄精还适用于干咳痰少、以及口干舌燥、或者是因疲倦而导致的头晕,腰膝酸软现象。
4、增强免疫力黄精还具有降血压、降低血糖、血脂的效果,同样还可以防止动脉粥硬化,达到延缓衰老与抗菌的作用,黄精还具有免疫激活的作用。
适宜人群阴虚肺燥、干咳少痰者黄精有滋阴润肺、脾阴益气功效,尤其适用于阴虚肺燥、干咳少痰、脾胃虚弱、肾虚精亏所致头晕、腰膝酸软、足软无力、须发早白者。
营养元素黄精含粘液质、淀粉、糖分、蒽醌类化合物、多种氨基酸、维生素。
药理研究证明,黄精能提高机体免疫功能,故增强人体抗病能力。黄精还有抗菌、降压、抗衰老、丽容颜、强精力的作用。
1、黄精的有效成分黄精多糖,具有降低血糖和糖化血红蛋白的作用,对肾上腺素引起的血糖过高有明显的抑制作用、经常食用,可有效降低血糖。
2、体外试验表明、黄精水提出液(1:320)对伤寒杆菌、金黄色葡萄球菌、抗酸杆菌有抑制作用,2%黄精在沙氏培养基内对常见致病真菌有不同程度的抑制作用。
3、黄精甲醇提取物40mg/只,正丁醇部分20mg/只,水层部分20mg/只,腹腔注射,对干冰-甲醇冷冻小鼠尾部1分钟,切尾法实验表明有止血作用,使小鼠出血量减少。
4、黄精多糖0.2%眼液滴眼,6次/天,或加服黄精多糖10mg/kg,2次/天,对兔实验性单纯疱疹病毒性角膜炎均有治疗作用。
营养素含量表营养素含量(每100克)单位热量326.72千卡碳水化合物52.30克蛋白质11.60克脂肪3.70克纤维素17.90克。
本发明的黑果花楸疏通微循环的饮料原材料中包含黑果花楸,黑果花楸具有如下的具体作用:
黑果花楸
功效:降血糖、保护眼睛、降血压、防衰老、维护保养肝脏、降低血脂、减肥瘦身、维护保养肠胃、避免老年痴呆、补充营养元素。
作用:
1、降血糖:黑果花楸可以补充身体需要的糖但是又不易使血糖升高,黑果花楸中含的糖是葡萄糖,葡萄糖的gi值仅为葡萄糖的19-23%。葡萄糖的基础代谢并不借助甘精胰岛素,仅仅直接进入人体肠道内被人体所消化应用。
2、保护眼睛:黑果花楸中含有叶黄素和原花青素,对预防近视保护眼睛很有作用。
3、降血压:黑果花楸对清理血管垃圾废弃物和控制血压都有作用,保健养生食物,高血压人群可以运用。
4、防衰老:黑果花楸又称作不老莓,具有抗皮肤氧化的功效,所含微量元素非常丰富,黑果花楸抗氧化指数远居第一位。
5、维护保养肝脏:黑果花楸中的与众不同营养元素可以促进肝脏的基础代谢,对于喝酒或者经常吃油腻感食物导致的脂肪肝和酒精肝有很好的避免作用。
6、降低血脂:黑果花楸对清理血管垃圾有很好的作用,含有许多维生素和碳
水化合物化合物,能清理血管垃圾废弃物还能摆脱并帮助清除血管内腔的脂肪。
7、减肥瘦身:黑果花楸有抗脂肪沉积的作用,食物中的碳水化合物化合物可以在乙状结肠中抑制脂肪被转换成小分子水,也就不易被身体消化,会马上被排出去人体以外,因而瘦身效果很好。
8、维护保养肠胃:俄罗斯黑果花楸每天按照说明服食,对肠胃有一定的维护保养作用,食物含有各种各样微量元素,对维护保养肠胃避免消化系统疾病很有帮助。
9、避免老年痴呆:黑果花楸也是有抗老年痴呆的作用,其中的膳食纤维素成份多种多样,能具备清理血管垃圾废弃物,提高小脑神经风采的作用。
10、补充营养元素:黑果花楸中的营养元素很多方位,含有身体需要的维生素、微量元素以及蛋白质和矿物质,对于经常没有时间好好调理营养搭配的人群非常合适,每天吃8—10个,能补充身体一天的营养元素所需。(单独补充黑果花楸,这些植物原料通过我们独特的萃取加工达到迅速通经络活血化瘀的作用。)
本发明的饮料具备补心血,益心气,安心神的效果,其中山楂醒脾开胃,更增加了脾的造血功效,黄精素来有灵芝草之称,补脾益气补肾益精是延年益寿的佳品,诸药合用,共奏健脾益气,养血补心,益智安神之效,更可增加心脏冠脉流量,调血脂、降血糖、抗衰老的功效,更值得说明的是,本发明的单独补充黑果花楸,还能够达到经络活血化瘀的作用。
可以理解,本发明是通过一些实施例进行描述的,本领域技术人员知悉的,在不脱离本发明的精神和范围的情况下,可以对这些特征和实施例进行各种改变或等效替换。另外,在本发明的教导下,可以对这些特征和实施例进行修改以适应具体的情况及材料而不会脱离本发明的精神和范围。因此,本发明不受此处所公开的具体实施例的限制,所有落入本申请的权利要求范围内的实施例都属于本发明所保护的范围内。
Claims (6)
1.一种黑果花楸疏通微循环的饮料,其特征在于,包括以下原材料:白芷、山楂、黄精、淡竹叶、龙眼肉、白术和黑果花楸调配而成。
2.根据权利要求1所述的黑果花楸疏通微循环的饮料,其特征在于,按上述比例调配时,原材料的具体质量为:白芷为0.3—0.7Kg,山楂为2.5—3.5kg,黄精为5—7kg、淡竹叶为30—35kg。
3.根据权利要求2所述的黑果花楸疏通微循环的饮料,其特征在于,原材料的具体质量还包括:龙眼肉为3.5—5kg,白术为1.5—2.5kg。
4.根据权利要求3所述的黑果花楸疏通微循环的饮料,其特征在于,所述原材料还包括干姜。
5.根据权利要求4所述的黑果花楸疏通微循环的饮料,其特征在于,所述干姜的具体质量为2—2.8kg。
6.根据权利要求1-5任一所述的黑果花楸疏通微循环的饮料,其特征在于,所述黑果花楸的具体质量为2—3kg。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310824880.3A CN116918925A (zh) | 2023-07-06 | 2023-07-06 | 一种黑果花楸疏通微循环的饮料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310824880.3A CN116918925A (zh) | 2023-07-06 | 2023-07-06 | 一种黑果花楸疏通微循环的饮料 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116918925A true CN116918925A (zh) | 2023-10-24 |
Family
ID=88376668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310824880.3A Pending CN116918925A (zh) | 2023-07-06 | 2023-07-06 | 一种黑果花楸疏通微循环的饮料 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116918925A (zh) |
-
2023
- 2023-07-06 CN CN202310824880.3A patent/CN116918925A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103263608B (zh) | 一种排毒养颜的中药原粉 | |
CN108323719A (zh) | 一种具有补肾乌发功能的黑色杂粮粉 | |
CN103191332A (zh) | 具有健胃消食作用的组合物及保健品 | |
CN101953413A (zh) | 无花果天然养颜减肥冷凉茶及其制备方法 | |
CN104922550A (zh) | 一种中药组合物及其应用 | |
CN104489516A (zh) | 提高肿瘤患者术后免疫功能的养生粥及制法 | |
CN111109602A (zh) | 一种适合糖尿病及高血脂肥胖人群的药膳功能性食品 | |
CN110584132A (zh) | 一种肾脏病特殊医学用途营养配方食品及其制备方法 | |
CN103157036A (zh) | 一种具有美肌丰胸功效的保健中药 | |
CN106343567A (zh) | 一种诺丽果口服液及其制备方法 | |
CN101862411B (zh) | 用于治疗痤疮粉刺的中药组合物 | |
CN1698875A (zh) | 一种治疗癌症的药酒 | |
CN113855766A (zh) | 一种可调理血压的银杏蛹虫草冲剂 | |
KR20020037218A (ko) | 한약재 증류수를 이용한 다이어트 음료수 제조방법 | |
CN111035001A (zh) | 排毒养颜延缓衰老的药食同源富硒养生组合物及制备方法 | |
CN105341574A (zh) | 一种牛蒡饮料的配方及生产工艺 | |
CN103829342A (zh) | 功能性保健饮料及其制备方法 | |
CN116918925A (zh) | 一种黑果花楸疏通微循环的饮料 | |
CN106177634A (zh) | 一种减肥瘦身复方制剂及其制备方法 | |
CN106234896A (zh) | 一种治疗肾病的保健饮品及其制备方法 | |
CN106418015A (zh) | 一种清调食补饮品的配方和制备方法 | |
CN104186849A (zh) | 一种消脂茶饮料 | |
CN110574848A (zh) | 一种氨基酸中药饮料及其制作方法 | |
CN102919438B (zh) | 一种红颜茶及其制作方法 | |
CN114767800A (zh) | 药食同源降血糖植物袋泡茶的配方及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |